THYROID EYE DISEASE (TED)
Clinical trials for THYROID EYE DISEASE (TED) explained in plain language.
Never miss a new study
Get alerted when new THYROID EYE DISEASE (TED) trials appear
Sign up with your email to follow new studies for THYROID EYE DISEASE (TED), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could ease bulging eyes in thyroid disease
Disease control Recruiting nowThis study tests a new medicine called MHB018A for people with long-term moderate-to-severe thyroid eye disease, which causes bulging eyes and discomfort. About 150 adults will receive either the drug or a placebo every 4 weeks for 6 months. The goal is to see if the drug reduces…
Matched conditions: THYROID EYE DISEASE (TED)
Phase: PHASE3 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Hope for thyroid eye disease: new drug shows promise in reducing eye bulging
Disease control Recruiting nowThis study tests an injection called MHB018A for people with moderate-to-severe thyroid eye disease, a condition that can cause bulging eyes and discomfort. About 258 adults who completed a prior study will receive the drug for 24 weeks to see if it reduces eye bulging and preven…
Matched conditions: THYROID EYE DISEASE (TED)
Phase: PHASE3 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Could cholesterol drugs and vitamin d tame thyroid eye disease?
Disease control Recruiting nowThis study tests whether statins (cholesterol-lowering drugs) and vitamin D supplements can calm inflammation and reduce eye bulging in people with active thyroid eye disease. About 120 adults with active disease and high cholesterol will be randomly assigned to one of four group…
Matched conditions: THYROID EYE DISEASE (TED)
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for thyroid eye disease: phase 3 drug trial launches in china
Disease control Recruiting nowThis phase 3 trial tests whether the drug ZL-1109 can reduce eye bulging and other symptoms in people with moderate to severe thyroid eye disease. About 99 Chinese adults with active disease will receive either the drug or a placebo. The study aims to see if the treatment can hel…
Matched conditions: THYROID EYE DISEASE (TED)
Phase: PHASE3 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
New injection for thyroid eye disease enters first human safety study
Disease control Recruiting nowThis early-stage study tests the safety of a new drug called GenSci098 in 76 adults with active thyroid eye disease (TED). Participants receive one or more injections under the skin, and researchers monitor for side effects and how the drug moves through the body. The goal is to …
Matched conditions: THYROID EYE DISEASE (TED)
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 08, 2026 12:00 UTC